Corrigendum to “Isoalantolactone/hydroxamic acid hybrids as potent dual STAT3/HDAC inhibitors and self-assembled nanoparticles for cancer therapy” [Euro. J. Med. Chem. (2024) 116765]

IF 5.9 2区 医学 Q1 CHEMISTRY, MEDICINAL European Journal of Medicinal Chemistry Pub Date : 2025-01-26 DOI:10.1016/j.ejmech.2025.117307
Hualong Mo , JieYing Liu , Zhengxi Su , Deng-Gao Zhao , Yan-Yan Ma , Kun Zhang , Qi Wang , Chun Fu , Yao Wang , Meiwan Chen , Burong Hu
{"title":"Corrigendum to “Isoalantolactone/hydroxamic acid hybrids as potent dual STAT3/HDAC inhibitors and self-assembled nanoparticles for cancer therapy” [Euro. J. Med. Chem. (2024) 116765]","authors":"Hualong Mo , JieYing Liu , Zhengxi Su , Deng-Gao Zhao , Yan-Yan Ma , Kun Zhang , Qi Wang , Chun Fu , Yao Wang , Meiwan Chen , Burong Hu","doi":"10.1016/j.ejmech.2025.117307","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":314,"journal":{"name":"European Journal of Medicinal Chemistry","volume":"286 ","pages":"Article 117307"},"PeriodicalIF":5.9000,"publicationDate":"2025-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0223523425000728","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
“异丙酸内酯/羟肟酸混合物作为有效的双重STAT3/HDAC抑制剂和自组装纳米颗粒用于癌症治疗”的勘误表[欧洲]。医学化学。(2024) 116765)
作者遗憾地通知,在图9中,对照组和18 (2.5 mg/kg)组使用了相同的TUNEL染色图像。我们已经用正确的图像替换了它。下面列出了正确的表格。下载:下载高分辨率图片(2MB)下载:下载全尺寸图片9. PBS、SAHA、18、18 NPs处理后肿瘤组织的H&;E染色和TUNEL染色分析。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
11.70
自引率
9.00%
发文量
863
审稿时长
29 days
期刊介绍: The European Journal of Medicinal Chemistry is a global journal that publishes studies on all aspects of medicinal chemistry. It provides a medium for publication of original papers and also welcomes critical review papers. A typical paper would report on the organic synthesis, characterization and pharmacological evaluation of compounds. Other topics of interest are drug design, QSAR, molecular modeling, drug-receptor interactions, molecular aspects of drug metabolism, prodrug synthesis and drug targeting. The journal expects manuscripts to present the rational for a study, provide insight into the design of compounds or understanding of mechanism, or clarify the targets.
期刊最新文献
Characteristics of Osteoclasts at Different Developmental Stages and Therapeutic Strategies Structure-activity relationship profiling of N-substituted 8-trifluoromethyl-9H-purin-6-amines as mitochondrial protonophores Multi-Target-Directed Chromone–Carboxamide Hybrids: Potent AChE/MAO-B Inhibitors with Anti-Aβ/Tau and Neuroprotective Activities Broad-Spectrum Inhibitor of Non-Structural Protein 2 Protease Shows Therapeutic Efficacy Against Venezuelan Equine Encephalitis Viral Infection The Application Prospects of Amino Acid Deprivation for Cancer Therapy
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1